Click on the buttons below (or keep scrolling) to discover what RaySearch has on display during RSNA 2025.
RaySearch at RSNA 2025
NOV. 30 - DEC. 4 | CHICAGO, ILLINOIS | BOOTH# 6139
Overview
RaySearch's Image-guided Liver Ablation module* enables advanced image-guided liver ablation by combining biomechanical deformable registration with Deep Learning Segmentation (DLS) for automatic delineation and precise target conformation.
Built with RaySearch's radiotherapy expertise —trusted by over 1,000 clinics worldwide—this solution combines fast algorithms, a streamlined workflow, and clinically validated evidence supporting improved progression-free survival. The result is a powerful, efficient, and intelligent solution that enables high-quality liver ablation treatments in just minutes.
*Subject to regulatory clearance in some markets. This functionality is not cleared for clinical use or commercial sale in the USA or Canada. However, RaySearch Laboratories is currently seeking research collaborations in these regions to support ongoing development and evaluation of this technology.
Learn more about Liver Ablation module here. Or continue to scroll to explore more of what RaySearch has on display at RSNA.
Watch this spotlight series episode, highlighting the development of the Image-guided Liver Ablation module.
Developing Image-Guided Liver Ablation
Development began in 2019 through collaboration with The University of Texas MD Anderson Cancer Center, with in-house written scripts for liver ablation treatments performed at MD Anderson. Since then, these scripts have gradually evolved through continuous refinement, seamlessly integrating into RaySearch’s software.
COVER-ALL Clinical Trial sessions at RSNA 2025
COMMAND AND CONTROL: NAVIGATING LIVER ABLATION WITH ARTIFICIAL INTELLIGENCE AT YOUR SIDE
Noreen Siddiqi, MD, Jessica A. Marques Silva, MD, Iwan Paolucci, PhD, A. Kyle Jones, PhD, Caleb Oconnor, Kristy K. Brock, PhD, Bruno C. Odisio, MD, PhD
On-demand
View Abstracts
Session Title: IREE. Interventional Radiology Education Exhibits
Session Start: 11/30/2025 7:30:00 AM
Location: LEARNING CENTER
POST-HOC ANALYSIS OF THE COVER-ALL TRIAL: THERMAL ABLATION OUTCOMES IN PATIENTS WITH COLORECTAL LIVER METASTASES
Jessica A. Marques Silva, MD, Iwan Paolucci, PhD, Noreen Siddiqi, MD, Caleb Oconnor, A. Kyle Jones, PhD, Kristy K. Brock, PhD, Bruno C. Odisio, MD, PhD
View Abstract
Session Title: M5B-SPIR. Interventional Radiology Monday Afternoon Poster Discussions II
Session Start: 12/1/2025 12:45:00 PM
Location: LEARNING CENTER
ONCOLOGICAL OUTCOMES FROM THE COVER-ALL TRIAL: SOFTWARE-BASED VERSUS VISUAL ASSESSMENT OF INTRAPROCEDURAL MINIMAL ABLATIVE MARGINS IN PERCUTANEOUS LIVER THERMAL ABLATION OF LIVER TUMORS
Jessica A. Marques Silva, MD, Iwan Paolucci, PhD, Noreen Siddiqi, MD, Caleb Oconnor, A. Kyle Jones, PhD, Kristy K. Brock, PhD, Bruno C. Odisio, MD, PhD
Session Title: W7-SSIR03. Science Session with Keynote: Interventional Radiology (Image-guided Therapy and Immune Modulation in Liver Oncology)
Session Start: 12/3/2025 3:00:00 PM
Location: E353A
From Image-guided ablation to radiology workstation: A Software Journey Towards comprehensive cancer care
LOCATION AND TIME:
Innovation Theater, Booth 3316, South Hall A
Wednesday, December 3, 2025 at 2:30 PM CST
SPEAKER:
Tom Niessen, MSc, is a Technical Product Manager at RaySearch Laboratories, leading development of software for Radiation Oncology and Radiology. With a background in physics and software engineering, he focuses on turning research innovations into clinically impactful products used in hospitals worldwide.
RaySearch will present its upcoming software, RayImaging, designed for advanced image viewing. RayImaging will include the essentials such as seamless PACS integration, flexible layouts, and support for displaying a broad range of medical images and DICOM objects.
In addition to these core functions, the platform will also offer specialized tools, that have been built from the last 15 years of RaySearch's experience developing imaging software. These include rigid image registration and fusion, deformable registration algorithms, manual and automatic segmentation capabilities, and workflow automation with python scripting. In the future, RayImaging will become a complete package with support for reporting, automated workflows, integration with information systems, and more.
This functionality is currently under development, not yet available for sale, and will require regulatory clearance before release.
External beam and brachytherapy planning in the same system. Our brachytherapy module is fully integrated into the EBRT workspace, giving clinics one unified environment for all modalities.
Key features include:
-
Hardware-agnostic with full vendor independence— model any applicator and deliver plans on any afterloader system, independent on vendor.
-
EQD2 – enabling dose evaluation across modalities for combined external beam and brachytherapy treatments.
-
Automation through scripting, templates and inverse planning workflows—reducing manual effort and increasing consistency.
-
Advanced dose computation including Monte Carlo algorithms (TG-186) for improved accuracy in heterogeneous tissues.
Learn more about Brachytherapy planning with RayStation. Or continue to scroll to explore more of what RaySearch has on display at RSNA.
For more than two decades, RaySearch Laboratories has advanced cancer treatment through software innovation — with the treatment planning system RayStation®, now used in over a thousand clinics worldwide. Building on this foundation, RaySearch has expanded its portfolio with RayCare® a modern oncology information system, and RayIntelligence® for data analytics.
The next step in the journey is extending RaySearch’s expertise in radiotherapy into the fields of interventional radiology and diagnostic radiology. By connecting diagnostic and therapeutic workflows, RaySearch continues its pursuit of a unified vision — comprehensive cancer care.
Attendees are invited to visit the RaySearch booth to see how this vision is already becoming reality today—from advanced adaptive solutions in radiotherapy to enhanced chemotherapy safety supported by DrugLog®, our quality-control solution for compounded medications.
RayStation and RayCare are subject to regulatory clearance in some markets. RayStation v2025 SP1 is pending FDA 510(k) clearance and is not currently available for sale or clinical use in the United States. Image-guided ablation, DrugLog, and RayImaging are currently under development, not yet available for sale in the United States, and will require regulatory clearance before release.